EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rasayana Chikitsa as Adjuvant Therapy in Cancer Survivorship: Mechanism and Evidence Review

Priya Goel, Sanjay Kumar Tiwari, Sonam Chauhan, Prachi Khandelwal, Himani Sharma

Journal of Health Synapse · 30.06.2026 · 58-64

DOI: 10.67529/jhs.v1i2.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health Synapse, online erschienen am 30.06.2026. Verfasst von Priya Goel und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer survivors increasingly experience treatment-related morbidity - fatigue, myelosuppression, neuropathy, and impaired quality of life (QoL) - that persists well beyond active oncological treatment. Rasayana Chikitsa, the Ayurvedic discipline of rejuvenation and Vyadhikshamatva (host-resistance) enhancement, has been explored as a complementary adjuvant strategy to mitigate these sequelae. This review synthesises classical conceptual foundations of Rasayana with contemporary mechanistic and clinical evidence, focusing on immunomodulation, antioxidant and anti-inflammatory pathways, and chemo-/radioprotective effects of key Rasayana dravyas such as Ashwagandha (Withania somnifera), Guduchi (Tinospora cordifolia), and compound formulations including Brahma Rasayana and Rasayana Avaleha. While preclinical data robustly support multi-targeted modulation of NF-κB, STAT3, and PI3K/AKT signalling along with antioxidant and immune-enhancing activity, clinical evidence remains limited to small trials, observational cohorts, and case reports. Rasayana therapy appears to offer a biologically plausible, low-toxicity adjunct for improving QoL and reducing treatment-related toxicity in cancer survivorship, but rigorous randomised controlled trials are needed before definitive clinical recommendations can be made.

Zitieren

APA

Goel, P., Tiwari, S. K., Chauhan, S., Khandelwal, P., & Sharma, H. (2026). Rasayana Chikitsa as Adjuvant Therapy in Cancer Survivorship: Mechanism and Evidence Review. Journal of Health Synapse, 58-64. https://doi.org/10.67529/jhs.v1i2.6

Vancouver

Goel P, Tiwari SK, Chauhan S, Khandelwal P, Sharma H. Rasayana Chikitsa as Adjuvant Therapy in Cancer Survivorship: Mechanism and Evidence Review. Journal of Health Synapse. 2026:58-64. doi:10.67529/jhs.v1i2.6

BibTeX
@article{Goel2026,
  author = {Goel, Priya and Tiwari, Sanjay Kumar and Chauhan, Sonam and Khandelwal, Prachi and Sharma, Himani},
  title = {Rasayana Chikitsa as Adjuvant Therapy in Cancer Survivorship: Mechanism and Evidence Review},
  journal = {Journal of Health Synapse},
  year = {2026},
  pages = {58--64},
  doi = {10.67529/jhs.v1i2.6}
}
Kostenlos starten →